The American Medical Association’s (AMA) to ease access to remote Cognitive Behavioral Therapy Monitoring

By SharpBrains | November 8, 2021

The Dig­i­tal Ther­a­peu­tics Alliance Wel­comes Deci­sion by the CPT® Edi­to­r­i­al Pan­el to Clar­i­fy Report­ing of Remote Cog­ni­tive Behav­ioral Ther­a­py Mon­i­tor­ing Ser­vices (press release): As the lead­ing inter­na­tion­al orga­ni­za­tion on dig­i­tal ther­a­peu­tic thought lead­er­ship and edu­ca­tion, the Dig­i­tal Ther­a­peu­tics Alliance (DTA) wel­comes the Amer­i­can Med­ical Association’s (AMA) Cur­rent Pro­ce­dur­al Ter­mi­nol­o­gy (CPT®) Edi­to­r­i­al Pan­el’s recent deci­sion to…

Read More

Neurostimulation device GammaSense by Cognito Therapeutics secures FDA Breakthrough Device Designation to explore Alzheimer’s Disease applications

By SharpBrains | January 14, 2021

Cog­ni­to Ther­a­peu­tics nets FDA break­through label for light, sound ther­a­py for Alzheimer’s dis­ease (Fierce Biotech): Using spe­cif­ic fre­quen­cies of flash­ing lights and sounds to stim­u­late the brain’s elec­tri­cal activ­i­ty, Cog­ni­to Ther­a­peu­tics believes it can help treat Alzheimer’s dis­ease by ener­giz­ing neu­rons and reac­ti­vat­ing the immune system.

Read More